Berwyn biopharm firm begins mid-stage testing of experimental therapy for Alzheimer's, Parkinson's

The start of the phase-II clinical trial was temporarily delayed by the Covid-19 pandemic.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.